Final diagnosis | n | Enhancement extent in early phase | Contrast agent wash-out within the lesion | |||||
---|---|---|---|---|---|---|---|---|
Hyper- | Iso- | Hypo- | Non- | Earlier | Same | Later | ||
Malignant lesions | 34 | 25 (73.5%) | 5 (14.7%) | 4 (11.8%) | 0 (0%) | 31 (91.2%) | 3 (8.8%) | 0 (0%) |
Benign lesions | 146 | 11 (7.5%) | 121(82.9%) | 12 (8.2%) | 2 (1.4%) | 19 (13.2%) | 125 (86.8%) | 0 (0%) |
Cholesterol polyp | 100 | 5 (5.0%) | 88 (88.0%) | 7 (7.0%) | 0 (0%) | 10 (10%) | 90 (90%) | 0 (0%) |
Adenoma | 29 | 5 (17.2%) | 21 (72.4%) | 3 (10.4%) | 0 (0%) | 7 (24.1%) | 22 (75.9%) | 0 (0%) |
Adenomyomatosis | 10 | 1 (10.0%) | 8 (80.0%) | 1 (10.0%) | 0 (0%) | 2 (20.0%) | 8 (80.0%) | 0 (0%) |
Chronic cholecystitis | 3 | 0 (0%) | 2 (66.7%) | 1 (33.3%) | 0 (0%) | 0 (0%) | 3 (100%) | 0 (0%) |
Gallstone | 2 | 0 (0%) | 0 (0%) | 0 (0%) | 2 (100%) | – | – | – |
Hyperplastic polyp | 1 | 0 (0%) | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) |
Metaplastic polyp | 1 | 0 (0%) | 1 (100%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (100%) | 0 (0%) |